Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,886
Total Claims
$1.2M
Drug Cost
2,958
Beneficiaries
$411
Cost/Patient
Risk Score Breakdown 35/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-51%
Opioid rate vs peers
1.2% vs 2.5% avg
-64%
Cost per patient vs peers
$411 vs $1,128 avg
+343%
Brand preference vs peers
37.2% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.2%
Opioid Rate
132
Opioid Claims
$3,691
Opioid Cost
18.9%
Long-Acting Rate
Brand vs Generic
Brand: 4,027 claims · $1.1M
Generic: 6,792 claims · $125K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rsvpref3 Antigen/As01e/Pf | 1,516 | $474K |
| Varicella-Zoster Ge/As01b/Pf | 1,083 | $231K |
| Rsv Vacc, Pref A And Pref B/Pf | 257 | $85K |
| Apixaban | 82 | $57K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $23K |
| Diphth,pertuss(Acell),tet Vac | 330 | $22K |
| Rivaroxaban | 33 | $21K |
| Insulin Aspart | 19 | $17K |
| Semaglutide | 16 | $16K |
| Empagliflozin | 15 | $13K |
| Budesonide/Formoterol Fumarate | 28 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $12K |
| Sitagliptin Phosphate | 18 | $10K |
| Exenatide Microspheres | 12 | $9,866 |
| Tiotropium Bromide | 18 | $9,575 |
Prescribing Profile
Patient Profile
76
Avg Age
58%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About